Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methylthiouracil (NSC-193526) is a thiourea antithyroid agent that inhibits the synthesis of thyroid hormone, and it is used to treat hyperthyroidism.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 9,500 | |||
50 mg | 在庫あり | ¥ 11,500 | |||
100 mg | 在庫あり | ¥ 17,000 | |||
200 mg | 在庫あり | ¥ 30,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Methylthiouracil (NSC-193526) is a thiourea antithyroid agent that inhibits the synthesis of thyroid hormone, and it is used to treat hyperthyroidism. |
In vitro | Methylthiouracil acts to decrease the formation of stored thyroid hormone, as thyroglobulin in the thyroid gland. Methylthiouracil is also used in combination with radioactive iodine. |
別名 | NSC-193526, NSC-9378, MTU |
分子量 | 142.18 |
分子式 | C5H6N2OS |
CAS No. | 56-04-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 27 mg/mL (189.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylthiouracil 56-04-2 Apoptosis Immunology/Inflammation MAPK NF-Κb Interleukin Antiviral TNF NF-κB ERK NSC 9378 Extracellular signal regulated kinases Nuclear factor-κB inhibit Tumor Necrosis Factor Receptor Inhibitor NSC193526 NSC9378 TNFR TNF Receptor Nuclear factor-kappaB Interleukin Related NSC 193526 NSC-193526 NSC-9378 MTU inhibitor